FDA 483 - Health Care Technology - April 25, 2022

An FDA inspection of Health Care Technology in Ashland, MA, revealed significant deficiencies across its quality system. The firm failed to establish and maintain adequate procedures for design control, purchasing, storage, device distribution, quality audits, management review, and employee training. These widespread issues indicate a fundamental lack of control over critical manufacturing processes for their medical devices.